Dr Reddy’s launches Amoxicillin tablets, capsules in US market

MUMBAI, Sept 20: Dr Reddy’s Laboratories today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension  — a bio-equivalent generic version of Amoxil—in the US Market.
Amoxicillin is a penicillin antibiotic used to treat many different types of infections caused by bacteria.
Amoxicillin tablets, capsules and oral suspension are approved by the United States Food and Drug Administration (USFDA), a company statement said here.
The Amoxil brand and generic tablets have US sales of about USD 22.2 million, capsules worth USD 67.2 million and oral suspension to nearly USD 89.5 million during 12 months ending June 2012, according to IMS Health. (PTI)


Please enter your comment!
Please enter your name here